is there an age limit for glp-1 Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Ozempic, Wegovy Can Affect Teens,

Though with similar effects as some pre-existing drugs (semaglutide, liraglutide, exenatide, etc.) targeting diabetes and obesity, tirzepatide is considered a first-in-class medication for demonstrating action on both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors

Puhl R, Brownell KD

Ivanova S, Delattre C, Karcheva-Bahchevanska D, Benbasat N, Nalbantova V, Ivanov K

CPL declares that there are no relationships or activities that might bias, or be perceived to bias, their work

Of course, but I find its best used as only a very rough estimate to help you get on track

In summary, these data suggest one of neuroprotective effects of GLP-1R agonists is inhibiting neuronal apoptosis